About Cardiovascular engineering inc
Cardiovascular Engineering Inc: Revolutionizing the Assessment of Arterial Stiffness and Pulsatile Hemodynamics
Cardiovascular diseases are one of the leading causes of death worldwide. According to the World Health Organization, an estimated 17.9 million people die each year due to cardiovascular diseases, accounting for 31% of all global deaths. The prevalence of these diseases has been increasing over time, making it a significant public health concern.
Cardiovascular Engineering Inc (CVE) is a company that aims to address this issue by developing research-grade noninvasive systems for comprehensive assessment of arterial stiffness and pulsatile hemodynamics. The company is located at 1 Edgewater Drive, Suite 201, Norwood, Massachusetts, 02062 under the leadership of Dr. Gary F Mitchell.
Arterial stiffness refers to the loss of elasticity in arteries due to aging or other factors such as hypertension or diabetes mellitus. It can lead to various cardiovascular complications such as heart attack and stroke. Pulsatile hemodynamics refers to the study of blood flow dynamics in arteries during systole and diastole phases.
CVE's noninvasive systems use advanced technologies such as pulse wave velocity (PWV), wave intensity analysis (WIA), and central blood pressure measurement (CBPM) to provide accurate assessments of arterial stiffness and pulsatile hemodynamics.
The PWV technology measures how fast pressure waves travel through arteries by analyzing pulse waves at two different points along an artery's length. This information helps determine arterial stiffness levels accurately.
The WIA technology analyzes changes in blood flow velocity during systole and diastole phases using ultrasound imaging techniques. This information helps identify any abnormalities in pulsatile hemodynamics that may indicate underlying cardiovascular conditions.
The CBPM technology measures central blood pressure directly from the aorta rather than peripheral arteries like traditional methods do. This approach provides more accurate readings since central blood pressure is more closely related to cardiovascular outcomes.
CVE's noninvasive systems are designed for research purposes and have been used in various clinical studies to assess arterial stiffness and pulsatile hemodynamics. The company's products have been well-received by researchers worldwide due to their accuracy, reliability, and ease of use.
In addition to its noninvasive systems, CVE also offers consulting services to help researchers design and conduct studies related to arterial stiffness and pulsatile hemodynamics. The company has a team of experts with extensive experience in cardiovascular research who can provide valuable insights into study design, data analysis, and interpretation.
CVE's commitment to innovation has led the company to develop new technologies that can further improve the assessment of arterial stiffness and pulsatile hemodynamics. For example, the company is currently working on developing a new technology called pulse wave analysis (PWA), which uses machine learning algorithms to analyze pulse waves' characteristics more accurately.
In conclusion, Cardiovascular Engineering Inc is a leading provider of noninvasive systems for comprehensive assessment of arterial stiffness and pulsatile hemodynamics. Its advanced technologies have revolutionized cardiovascular research by providing accurate assessments that were previously impossible or difficult to obtain. With its commitment to innovation, CVE is poised for continued success in improving cardiovascular health worldwide.
cardiovascularengineering.com